CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) EPS (Diluted) : $-0.00 (TTM As of Jun. 2018)

CTT Pharmaceutical Holdings EPS (Diluted) Chart

CTT Pharmaceutical Holdings Annual Data
	Trend	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15
EPS (Diluted)		Get a 7-Day Free Trial					4.00	-1.10	-0.01	0.01	-0.07

CTT Pharmaceutical Holdings Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Mar17	Jun17	Mar18	Jun18
EPS (Diluted)	Get a 7-Day Free Trial															-0.01	-	-0.01	-	-

Competitive Comparison of CTT Pharmaceutical Holdings's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, CTT Pharmaceutical Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CTT Pharmaceutical Holdings's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CTT Pharmaceutical Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where CTT Pharmaceutical Holdings's PE Ratio falls into.

CTT Pharmaceutical Holdings EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

CTT Pharmaceutical Holdings's Diluted EPS for the fiscal year that ended in Dec. 2015 is calculated as

CTT Pharmaceutical Holdings's Diluted EPS for the quarter that ended in Jun. 2018 is calculated as

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CTT Pharmaceutical Holdings  (OTCPK:CTTH) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

CTT Pharmaceutical Holdings EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description